Biotech

All Articles

Analysts go into Avidity's DMD win, uncovering nuances in data

.Avidity Biosciences pleased clients along with stage 1/2 records in Duchenne muscle dystrophy (DMD)...

Actinogen's cortisol blocker neglects stage 2 clinical depression research

.Actinogen Medical's cortisol blocker has missed the major endpoint of a stage 2 research in depress...

Bivictrix decides going exclusive only method to take ADC right into medical clinic

.Antibody-drug conjugates (ADCs) have gone to the facility of lots of a billion-dollar biobuck licen...

TPG bests up funds to $580M for financial investments all over life scientific researches

.Possession supervisor TPG, which has actually assisted biotechs including Sionna Therapies and also...

Merck stops stage 3 TIGIT trial in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT course has endured yet another obstacle. Months after shuttering a period 3 ...

After a hard year, Exscientia folds in to Recursion

.After a year defined through pipeline hairstyles, the variation of its own CEO as well as layoffs, ...

Cullinan, after $25M bargain, return bispecific to Port

.Cullinan Therapy was actually excited enough with Harbour BioMed's bispecific invulnerable activato...

A nearer examine Ferocious Biotech's Tough 15

.Within this week's episode of "The Best Pipe," our experts're diving in to Strong Biotech's annual ...

Lilly encounters phase 2 breakdown of tau-targeting med

.The confetti is still flying coming from Eli Lilly's event commemorating the approval of Alzheimer'...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and ...